Picture of Mustang Energy logo

MUST Mustang Energy News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

REG - Mustang Energy PLC - Half-year Report

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220907:nRSG5058Ya&default-theme=true

RNS Number : 5058Y  Mustang Energy PLC  07 September 2022

 Wednesday 7 September 2022

 

 

Mustang Energy PLC

Interim Condensed Financial Statements

Half Year to 30 June 2022

 

 

Mustang Energy PLC (the "Company"), announces its unaudited interim results
for the half year ended 30 June 2022.

Copies of this interim report will be made available on the Company's
website, www.mustangplc.com (http://www.mustangplc.com)

 

ENQUIRIES

For further information, please visit www.mustangplc.com
(http://www.mustangplc.com) , follow us on Twitter @Mustang_Plc
(https://twitter.com/Mustang_Plc) , or contact:

Mustang Energy PLC

Dean Gallegos, Managing Director

dg@mustangplc.com

+61 416 220 007

Interim Management Report

 

As you are aware, in March 2021 the Company announced a Strategic Alliance and
Placing to Acacia Resources Limited ("Acacia"). Acacia was established in 2012
with a current focus on minerals involved in the energy transition process.
The principal purposes of the Placing and the Strategic Investment was for the
Company and Acacia to invest together in manufacturing assets involved in the
energy transition process with a focus on energy storage and the battery value
chain.  Additionally, it is also the intention to participate in the
development of renewable energy projects where there is scope to include
stationary energy storage. At the same time as the Placing Acacia also
acquired existing shares from two existing shareholders and as a result of the
Placing and these purchases became the Company's largest shareholder with
24.03%.

In April 2021 the Company announced that it had entered into an investment
agreement dated 21 April 2021 (the "Investment Agreement") where it agreed to
acquire a 22.1% interest in VRFB Holdings Limited ("VRFB-H") for US$7.524
million ("Acquisition (Stage 1)"), which was funded through the issue of
US$8,000,000 10 per cent. unsecured convertible loan notes (the "CLNs") to
certain investors, including the Company's 24.03% shareholder Acacia. VRFB-H
owns a 50% interest in Enerox Holdings Limited ("EHL") with EHL owning a 100%
interest in Enerox GmbH ("Enerox").

Mustang's 22.1% investment into VRFB-H constitutes a reverse takeover under
the Listing Rules.  As a result, the Company's shares are suspended until the
Company publishes a prospectus for the readmission of the ordinary share
capital of the Company to trading on the London Stock Exchange.

Enerox is an Austrian-based vanadium redox flow battery manufacturer. Bushveld
Minerals Limited ("BMN") owns a 50.5% interest in VRFB-H and Acacia owns the
remaining 27.4%. Enerox has invested more than 20 years of research and
development into its CellCube energy storage system. Their vanadium-based
technology is known to be state-of-the-art in the battery market and has
already deployed more than 130 systems / 23 MWh across 5 continents.

In July 2021 the Company was advised that a claim form had been issued in the
English High court by Garnet Commerce Limited ("Garnet") against VRFB-H and
EHL. Garnet owns the remaining 50% interest in EHL. Garnet's claim form sought
declarations against VRFB-H concerning an alleged breach of the joint venture
agreement in relation to EHL, in respect of the indirect investment into EHL
through VRFB-H by Mustang, as announced on 27 April 2021.

On 25 January 2022, the Company entered a loan agreement with BMN pursuant to
which BMN provided the Company with an unsecured non-interest-bearing loan of
US$220,000 (the "Loan"). The Loan is repayable in full at any time on or prior
to 31 December 2023 (the "Repayment Date") and is repayable in any event if
the Company raises any debt or equity capital of no less than £1 million
(excluding any conversion of the CLNs into new MUST Shares) prior to the
Repayment Date. At the option of the Company, the Loan is repayable either by
way of a single repayment in cash or by the issue of such number of new MUST
Shares as is equal to the Loan (the "Loan Shares"). The issue price of the
Loan Shares is the greater of £0.20 per MUST Share and the average
volume-weighted average price of a MUST Share for the consecutive 10 dealing
days ending on the dealing day immediately preceding the repayment date. The
Loan shall be waived in full if the Backstop is implemented prior to the
Repayment Date.

 

On 8 March 2022 the Company advised that VRFB-H had successfully defended
Garnet's claims. The judgment vindicated the position that the investment by
VRFB-H into EHL, funded as it was partly by an investment by the Company, was
permitted and did not violate any agreements. Accordingly, the investment by
Mustang into VRFB-H, and the investment by VRFB-H into EHL, continues to
remain effective. The Company is now in the process of preparing a prospectus
so as to facilitate the relisting of the Company's shares.

On 28 March 2022 the parties to the Investment Agreement and as subsequently
amended and restated relating to the Company's conditional purchase of shares
in VRFB-H ("VRFB Share Purchase"), including the Company, agreed to extend the
longstop date to satisfy the principal outstanding condition of the VRFB Share
Purchase, namely the publication by the Company of a prospectus and the
readmission of the ordinary share capital of the Company ("MUST Shares") to
listing and trading (together, "Readmission") by no later than 31 July 2022
(the "Longstop Extension"). In turn, the Longstop Extension was mirrored in
the Company's convertible loan note instrument (the "CLN Instrument") pursuant
to which it issued US$8 million 10% CLNs to certain investors (the "CLN
Holders") such that the maturity date of the CLNs was, as agreed between the
Company and the CLN Holders, extended to 31 July 2022 (or such later date as
may be agreed between the Company and the CLN Holders) (the "Maturity Date").

 

Principal risks and uncertainties

 

The principal risks and uncertainties facing our business are monitored on an
ongoing basis. The board of directors have reviewed the principal risks and
uncertainties disclosed in the 2021 annual report and concluded that they
remain applicable for the second half of the financial year. A detailed
description of these risks and uncertainties is set out on pages 18 to 19 of
the 2021 annual report.

Alan Broome, AM Chairman

6 September 2022

 
Statement of Directors' Responsibilities

 

The directors are responsible for preparing the interim management report in
accordance with applicable law and regulations. The directors confirm that the
interim condensed financial information has been prepared in accordance with
International Accounting Standard 34 ('Interim Financial Reporting') as
endorsed for use in the United Kingdom.

 

The interim management report includes a fair review of the information
required by the Disclosure and Transparency Rules paragraphs 4.2.7 R and 4.2.8
R, namely:

 

·     the interim condensed financial statements, which have been
prepared in accordance with applicable accounting standards, give a true and
fair view of the assets, liabilities, financial position, and profit or loss
of the issuer as required by DTR 4.2.4R; and

 

·     an indication of important events that have occurred during the six
months ended 30 June 2022 and their impact on the condensed set of financial
information; and

 

·     material related-party transactions during the six months ended 30
June 2022 and any material changes in the related-party transactions described
in the Annual report and accounts 2021.

 

The interim management report was approved by the Board of Directors and the
above responsibility statement was signed on its behalf by:

 

 

Dean Lloyd Gallegos

Director

 

Date: 6 September 2022

 

 

Condensed Statement of Comprehensive Income

 

 

 

                                                                                     6 month        6 month

period ended
period ended

30 June 2022
30 June 2021

(unaudited)
(unaudited)
                                                                               Note  £              £
 Administrative expenses                                                             (357,679)      (134,903)

 Operating loss                                                                       (357,679)     (134,903)
 Finance Costs                                                                       (386,029)
 Other gains                                                                         89,997         -
 Loss on foreign exchange                                                            (113,121)      -

 Loss before taxation                                                                (766,832)       (134,903)

 Taxation                                                                            -
 Loss for the period                                                                 (766,832)       (134,903)
 Other comprehensive income for the period                                           -              -
 Total comprehensive loss for                                                        (766,832)      (134,903)

 the period attributable to the equity owners

 Loss per share from continuing operations attributable to the equity owners
                                                                               2     (0.07)

 Basic loss per share                                                                (0.07)         (0.01)

 Diluted loss per share                                                                             (0.01)

 (pence per share)

 

Condensed Statement of Financial Position
 
 

 

 

                                            As at         As at
                                            30 June 2022  31 December 2021
                                            (unaudited)   (unaudited)
                                      Note  £             £

 Assets

 Non-current assets

 Property, plant and equipment              1,273         1,525
 Investments                          3     6,179,877     5,573,333

 Total non-current assets                   6,181,150     5,574,858

 Current assets
 Trade and other receivables          4     16,618        13,117
 Cash and cash equivalents                  220,181       394,700

 Total current assets                       236,799       407,817
 Total assets                               6,417,949     5,982,675

 Equity and liabilities

 Equity attributable to shareholders
 Share capital                        8     102,816       102,816
 Share premium                        9     810,219       810,219
 Share based payments reserve               91,100        91,100
 Retained deficit                           (2,170,969)   (1,404,137)

 Total equity                               (1,166,834)   (400,002)

 Liabilities

 Current liabilities
 Trade and other payables             5     75,706        52,725
 Borrowings                           6     7,328,371     6,329,952

 Total current liabilities                  7,404,077     6,382,677

 Non-current liabilities
 Borrowings                           7     180,706       -

 Total liabilities                          7,584,783     6,382,677

 Total equity and liabilities               6,417,949     5,982,675

 

 

 

Condensed Statement of Changes in Equity
 

                                                                                 Share based payments

                                                            Share premium        reserve

                                           Share capital    account                                     Retained      Total equity

                                                                                                        deficit
                                                  £         £                    £                      £             £
 On 1 January 2021 (audited)               84,000           654,000              91,100                 (501,513)     327,587

 Period ended 30 June 2021
 Total comprehensive loss for the period   -                -                    -                      (134,903)     (134,903)
 Issue of share capital                    18,816           169,344              -                      -             188,160

 Balance as at 30 June 2021 (unaudited)    102,816          823,344              91,100                 (634,416)     380,844

 On 31 December 2021                          102,816             810,219          91,100               (1,404,137)       (400,002)

 (audited)

 Period ended 30 June 2022

 Total comprehensive loss for the period

                                           -                -                    -                      (766,832)     (766,832)

 Balance as at 30 June 2022                102,816          810,219              91,100                 (2,170,969)   (1,166,834)

 (unaudited)

 

 

Statement of Cash Flows
 
 
                                                                 6 months to    6 months to

30 June 2022

              30 June 2021 (unaudited)
                                                                 (unaudited)
                                                           Note  £              £

 Cash flow from operating activities
 Cash absorbed by operations                               11     (337,947)     (10,704)
 Cash flow from operating activities                              (337,947)     (10,704)
 Financing activities
 Proceeds from issue of shares (net of share issue costs)        -              188,160
 Proceeds from loans and borrowings                              163,428        -
 Net cash generated from financing activities                    163,428        -
 Net decrease in cash and cash equivalents                       (174,519)      (177,456)
 Cash and cash equivalents at beginning of period                394,700        345,200
 Cash and cash equivalents at end of period                      200,181        522,656

 

 

1      Notes to the interim financial statements

 

General information

Mustang Energy PLC (the "Company") is a Public Limited Company incorporated
and domiciled in England and Wales. The interim condensed financial statements
for the six months ended 30 June 2022. The address of the Company's registered
office is 48 Chancery Lane, c/o Keystone Law, London, WC2A 1JF. The interim
condensed financial statements of the Company were authorised for issue in
accordance with a resolution of the Directors on 5 September 2022.

 

The audited financial statements for the year ended 31 December 2021 are
publicly available on the Company's website: www.mustangplc.com. The interim
condensed financial statements have been prepared on a going concern basis.

 

1.1     Basis of preparation and statement of compliance

The interim condensed financial statements are for the six months ended 30
June 2022 and have been prepared in accordance with IAS 34 'Interim Financial
Reporting'; the International Accounting Standards endorsed for use in the
United Kingdom ("IFRS"); on a going concern basis and under the historical
cost convention except for revaluation of certain financial instruments.

 

The interim condensed financial statements do not comprise statutory accounts
within the meaning of section 434 of the Companies Act 2006. They do not
include all of the information required in annual financial statements in
accordance with IFRS, and should be read in conjunction with the financial
statements for the year ended 31 December 2021.

 

The condensed financial information for the year ended 31 December 2021 does
not constitute the Company's statutory accounts for that year, but is derived
from those accounts. Statutory accounts for the year ended 31 December 2021
have been delivered to the Registrar of Companies. The auditors reported on
those accounts: their report was unqualified, did not draw attention to any
matters by way of emphasis and did not contain a statement under s498(2) or
(3) of the Companies Act 2006.

 

The condensed financial information for the period ended 30 June 2022 have not
been audited or reviewed in accordance with the International Standard on
Review Engagements 2410 issued by the Auditing Practices Board.

 

1.2      Accounting policies, critical estimates and judgements

The accounting policies, methods of computation, critical estimates and
judgements followed in the interim condensed financial statements are in
accordance with those followed in preparing the financial statements for the
year ended 31 December 2021.

 

A number of amendments to IFRS became applicable for the current reporting
period. The Company did not have to change its accounting policies or make
retrospective adjustments as a result of adopting these amended standards.

 

The preparation of the interim condensed interim financial statements requires
directors to make judgements, estimates and assumptions that affect the
application of accounting policies and the reported amounts of assets and
liabilities, income and expense. Actual results may differ from these
judgements and estimates.

 

In preparing these interim condensed financial statements, the significant
judgements made by directors in applying the Company's accounting policies and
the key sources of estimation uncertainty were the same as those that applied
to the audited financial statements for the year ended 31 December 2021. As
stated in the Interim Management Report, despite holding a 22.1% interest, the
Company has not been able to exercise significant influence over its
investment in VRFB-H and thus the Company has not applied equity accounting in
preparing these interim condensed financial statements. The Company's
investment in VRFB-H continues to be accounted for as a financial asset held
at fair value through profit or loss.

 

 
2      Loss per share
 
 
 
                                                                                         6 month        6 month period ended

period ended
30 June 2021

30 June 2022
                                                                                         £              £

 Number of shares

 Weighted average number of ordinary shares for basic earnings per share                 10,281,600     9,330,033

 Weighted average number of ordinary shares for diluted earnings per share                11,731,600     10,780,033

 
 Loss

 Loss for the period from continued operations               (766,832)   (134,903)

 

 Loss for basic and diluted earnings per share being net profit attributable to
 equity shareholders of the company for continued operations

                                                                                             (766,832)   (134,903)

 
 
 Loss per share for continuing operations

 Basic loss per share                                  (0.07)   (0.01)

 Diluted loss per share                                (0.07)   (0.01)

 
       The share options and warrants are considered to be anti-dilutive.

 

 
3     Investments

 

 

                                  30 June                                 31 December

2022
2021
                                              £                           £

     Shares in unlisted entities  6,179,877                               5,573,333

     Movements in non-current investments
                                                                          Shares in unlisted investments
                                                                          £
     Cost or valuation
     At 1 January 2022                                                    5,573,333
     Fair value adjustment due to changes in exchange rate                606,544

     At 30 June 2022                                                      6,179,877

     Carrying amount
     At 30 June 2022                                                      6,179,877

     At 31 December 2021                                                  5,573,333

 

The Directors of the Company consider the fair value of the investment in
VRFB-H at the reporting date to be equal to the original cost of $7,524,000,
translated at closing foreign exchange rates, as the Directors estimate that
has been no material change in the fair value of the investment between the
acquisition and the reporting dates. The gain in the fair value due to changes
in exchange rates is included in profit or loss within exchange losses

 

 
4      Trade and other receivables
 
                                30 June  31 December

2022
2021
                                £        £

 Other receivables              9,786     7,665

 VAT recoverable                2,457    116

 Prepayments                    4,375             5,336

 
                 16,618           13,117

 

 

5      Trade and other payables
 
                                                 30 June  31 December

2022
2021
                                                 £        £

 Trade payables                                  25,606                 693

 Accruals                                        37,300            49,400

 Other payables                                  12,000                   -
 Other taxation and social security              800                 2,632

 
                 75,706  52,725

 
 
 
 
6      Current liabilities - Borrowings
 
                                            30 June    31 December

2022
2021
                                            £          £

     Convertible loan notes                 7,328,371  6,329,952

 

On 27 April 2021 the Company entered into an investment agreement to acquire a 22.1% interest ("Investment Agreement"") in VRFB-H for a consideration of US$7,524,000. The investment was financed through the issue of US$8,000,000 convertible loan notes ("CLNs"), with surplus funds being used to pay associated costs and working capital.

 

The principal terms of the CLNs, as at 31 December 2021, are detailed below:
 
-     The CLNs attract an interest rate of 10% per annum, payable in cash or shares in the Company at the election of the Company;
 
-     The CLNs are redeemable at par together with outstanding accumulated interest on 28 January 2022 unless converted into shares in the Company at the option of the Company;
 
-     The CLNs are convertible into shares in the Company, calculated by dividing the nominal value (and accrued interest, if applicable) of the CLNs (using the average USD/GBP closing exchange rate as shown on Bloomberg over the five trading days prior to conversion) by 18 pence ("MUST Conversion Shares"), by no later than 31 July 2021 (such date of conversion being the "Conversion Date") and the publication of a prospectus by the Company and readmission of the Company to listing and trading ("Readmission") on the London stock exchange;
 
-     The CLN holders will receive warrants to subscribe for new shares in the Company (one warrant being issued for every two MUST Conversion Shares held), exercisable at a price per share of
30 pence. The warrants have an expiry period of three years from the Conversion Date;
 
-     In circumstances where the Company is in default, the Company is obliged to exercise a backstop mechanism, whereby BMN has agreed to issue new ordinary shares in its capital ("BMN Shares") to CLN holders in respect of the principal amount and accrued interest under the CLNs (the "Backstop") in return for the Company: (i) transferring to BEL all of the Company's shares in VRFB-H; and (ii) paying a fee to BMN of an amount equal to 5% of the MUST Capital Raise (including both principal and interest), to be satisfied by the issue of new ordinary shares in the Company at a price of 20 pence per share (the "Backstop Fee"). In consideration of BMN providing the Backstop, the Backstop Fee is payable in the event of Readmission not occurring by the aforesaid date or immediately prior to completion of Readmission.
 
-     In the event of change of control of the Company, the CLNs and accumulated interest become redeemable either in cash or in shares in the Company at the option of the CLN holders via the conversion process specified above.
 
The terms of the CLNs were amended during the period ended 30 June 2022 as follows:
 
1.           The Backstop fee was reduced from 5% to 2%;
 
2.       Call and put options were granted between the Company and BEL which in substance allowed the Company to reverse the Backstop if it was triggered and the court case was ultimately successful;
 
3.           The Readmission Longstop Date of the CLN was extended to 31 July 2022; and
 
4.           The Conversion Price was reduced from £0.20 to £0.18.
 
The terms of the CLN were amended further after the period end as detailed in note 10.
 
The CLN is accounted for as a financial liability with an embedded derivative representing the Company's option to convert the CLN into shares.
 
The valuation of the embedded derivate is driven by unobservable inputs such as the expected timing and probability of Readmission, the Company's share price at Readmission as well as the expected USD/GBP exchange rate. The value of the conversion derivate remains £nil as at 30 June 2022 (Dec 2021: £nil) due to uncertainty regarding the Readmission process.
 
As disclosed above, as at 30 June 2022 the terms of the CLN were extended with the principal and accumulated interest becoming redeemable at par on 28 August 2022. This represents a modification of the financial liability, with a gain of £89,997 recognised in other gains in profit or loss.
 
The movements in the carrying value of the CLN liability are detailed below:
 
                                                 £
 Balance at 1 January 2022                    6,329,952

 Interest charge                              386,029
             Gain on modification             (89,997)
 Foreign exchange difference                  702,387

 Balance at 30 June 2022                      7,328,371

 
 
7          Non-current liabilities
                                    Period ended  Year ended

30 June
31 December

2022
2021

£
£

 Working capital loan               180,706                         -

 
               180,706                    -

 
 
On 25 January 2022, the Company received a working capital loan from BMN of US$220,000. The loan is repayable at the earlier of: 31 December 2023 or the Company raising £1 million of new funding. The Company can redeem the loan at any time, either in cash or in shares in the Company, valued at the higher of £0.20 or the volume weighted average price on the preceding 10 trading days.
 
The option to convert the loan into Company shares is a non-closely embedded derivative. The fair value of the derivative at 25 January 2022 and 30 June 2022 is trivial and is thus deemed to be £nil.
 
The loan is a financial liability carried at amortised cost with an effective interest rate of nil.
 
The movements in the carrying value of the loan liability are detailed below:
 
                                 £
 Balance at 1 January 2022    -

 Inception 25 January 2022    163,428
 Foreign exchange difference  17,278

 Balance at 30 June 2022      180,706

 
 
8      Share Capital
                                                                         Period ended  Year ended

30 June
31 December

2022
2021

£
£
 Ordinary Share capital

 Issued

 10,281,600 (2021 - 10,281,600) Ordinary shares of 1p each               102,816       102,816

 
               102,816  102,816

 
 
The Ordinary shares have attached to them full voting rights, dividend and capital distribution rights (including on a winding up) but they do not confer any rights of redemption.
 

 

9      Share premium account
 
                                                      Period ended  Year ended

30 June
31 December

2022
2021

£
£

 At the beginning of period                           810,219       654,000

 Issue of new shares                                  -             150,444

 Less directly attributable issue costs               -             (13,125)
 Exercise of warrants                                 -             18,900

 
 At end of period              810,219  810,219

 
 
10     Events after reporting date
 
On the 3 August 2022 the Company disclosed that it had entered into a conditional agreement with Acacia to acquire its 27.4 per cent. interest ("Acquisition (Stage 2)") in VRFB-H. The consideration for the Acquisition (Stage 2) is US$10,548,945 to be converted to GBP:£ using an exchange rate of GBP£1.00/US$1.225 and to be satisfied by the proposed issue of 43,056,989 new ordinary shares in the capital of the Company issued at 20 pence each (the "Consideration Shares").
 
The Consideration Shares proposed to be issued to Acacia on completion of the Acquisition (Stage 2), combined with Acacia's existing shareholding in the Company, the shares proposed to be issued as a result of the conversion of the US$2.3 million principal amount of CLNs held by Acacia (together with accrued interest thereon) and the exercise of certain options and warrants held by Acacia (assuming that such options and warrants are converted in full into MUST shares), will mean that Acacia will hold in excess of 50% of the issued capital of the Company.
 
On the 2 September 2022 the parties to the Investment Agreement agreed to amend the Longstop Extension and Maturity Date to the 28 October 2022.  The Company was notified by a Noteholder of CLNs (the "Redeeming Noteholder") with a principal amount of US$1.25 million (and accrued and unpaid interest thereon) that it wishes to effect the Backstop in respect of its CLNs (the "Backstop CLNs"). BMN negotiated with the Redeeming Noteholder to acquire the Backstop CLNs by the issue of BMN shares are currently in discussions to finalise the arrangements to effect the Backstop CLNs.
 

 

11     Cash generated from operations
 
 
                                                                            6 month                            6 month

period ended
period ended

30 June 2022
30 June 2021

£
£
 Loss for the period after tax                                                 (766,832)                             (134,903)

 Adjustments for:

 Depreciation and impairment of property, plant and equipment                          252                                   169

 Equity settled share-based payment expense                                                 -                                    -

 Fair value adjustment due to changes in exchange rate                          (606,544)                                        -

 Foreign exchange movement on working capital loan                                  17,278                                        -

 Movements in working capital

 Increase in trade and other receivables                                           (3,501)                              (1,739)

 Increase/(decrease) in trade and other payables                              1,021,400                              (125,769)

                                                                            (337,947)                          (10,704)

 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR FLFSRASIRIIF

Recent news on Mustang Energy

See all news